Worth reading
49Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1247100
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of gratis stock options (the 28th Stock Acquisition Rights)
Who receives how much
1,247,100 shares of common stock (12,471 stock acquisition rights, 100 shares per right)
Directors of the company3 / 652 rights
The Company's executive officers, including directors serving concurrently as executive officers4 / 1,001 rights
The Company's employees50 / 9,568 rights
Directors of the company's subsidiaries1 / 500 rights
Employees of the company's subsidiaries1 / 750 rights
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
No cost (¥0) per stock acquisition right
Total issue value
No cost (¥0)
Terms of the stock acquisition rights
Exercise price
Average closing price in the month preceding the month of allocation × 1.05 (a 5% premium). However, the exercise price will not be lower than the closing price on the allocation date. Adjustment provisions apply in connection with stock splits, reverse stock splits and issuances below market value, among other events. The floor for adjustments is Not disclosed
Exercise period
2 July 2028 to 16 June 2036
Number of Stock Acquisition Rights
Total issuance: 12,471 rights. Outstanding unexercised rights: Not disclosed
Reason for acquisition without consideration
The company may acquire the stock acquisition rights at no cost if approval is granted for a merger or other transaction in which the company becomes the surviving entity's absorbed company, or if a holder becomes unable to exercise the rights under the exercise conditions before exercising them.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
The holder must be a director, executive officer, employee or external collaborator of the company or one of its affiliated companies at the time of exercise. In the event of retirement upon expiration of a term of office or mandatory retirement, the rights may be exercised for 3 years after retirement.
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 3 / Number of rights allotted 652 rights, Category The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number of rights allotted 1,001 rights, Category The Company's employees / Number of Employees 50 / Number of rights allotted 9,568 rights, Category Directors of the company's subsidiaries / Number of Employees 1 / Number of rights allotted 500 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number of rights allotted 750 rights
Basis for determining the amount to be paid
The exercise price will be calculated by multiplying the average closing price on each trading day in the month preceding the month of allocation by 1.05. However, if this amount is lower than the closing price on the allocation date, the closing price on the allocation date will apply.
Procedures under the Corporate Code of Conduct
The resolution was approved at the board of directors meeting held on 17 June 2026, pursuant to Articles 236, 238 and 240 of the Companies Act. Obtaining an opinion from an independent third party and confirming shareholders' intentions: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of gratis stock options (the 28th Stock Acquisition Rights) |
| Number of shares to be issued or disposed of | 1,247,100 shares of common stock (12,471 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | No cost (¥0) per stock acquisition right |
| Total issue value | No cost (¥0) |
| Intended allottee | Category Directors of the company / Number of Employees 3 / Number of rights allotted 652 rights, Category The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number of rights allotted 1,001 rights, Category The Company's employees / Number of Employees 50 / Number of rights allotted 9,568 rights, Category Directors of the company's subsidiaries / Number of Employees 1 / Number of rights allotted 500 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number of rights allotted 750 rights |
| Basis for determining the amount to be paid | The exercise price will be calculated by multiplying the average closing price on each trading day in the month preceding the month of allocation by 1.05. However, if this amount is lower than the closing price on the allocation date, the closing price on the allocation date will apply. |
| Exercise price | Average closing price in the month preceding the month of allocation × 1.05 (a 5% premium). However, the exercise price will not be lower than the closing price on the allocation date. Adjustment provisions apply in connection with stock splits, reverse stock splits and issuances below market value, among other events. The floor for adjustments is Not disclosed |
| Exercise period | 2 July 2028 to 16 June 2036 |
| Number of Stock Acquisition Rights | Total issuance: 12,471 rights. Outstanding unexercised rights: Not disclosed |
| Conditions for lifting transfer restrictions | The holder must be a director, executive officer, employee or external collaborator of the company or one of its affiliated companies at the time of exercise. In the event of retirement upon expiration of a term of office or mandatory retirement, the rights may be exercised for 3 years after retirement. |
| Reason for acquisition without consideration | The company may acquire the stock acquisition rights at no cost if approval is granted for a merger or other transaction in which the company becomes the surviving entity's absorbed company, or if a holder becomes unable to exercise the rights under the exercise conditions before exercising them. |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 3 / Number of rights allotted 652 rights, Category The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number of rights allotted 1,001 rights, Category The Company's employees / Number of Employees 50 / Number of rights allotted 9,568 rights, Category Directors of the company's subsidiaries / Number of Employees 1 / Number of rights allotted 500 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number of rights allotted 750 rights |
| Procedures under the Corporate Code of Conduct | The resolution was approved at the board of directors meeting held on 17 June 2026, pursuant to Articles 236, 238 and 240 of the Companies Act. Obtaining an opinion from an independent third party and confirming shareholders' intentions: Not disclosed |
Items this document does not state (15)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enhance the motivation and morale of the eligible recipients and further strengthen the company's cohesion, with a view to achieving medium- to long-term earnings growth and increasing corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.